The British journal of dermatology

publication venue for

The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. 2020
A case of necrotizing fasciitis due to Streptococcus pneumoniae. 1995
A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council. 2024
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical trial. 2024
Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape.. 190. 2024
Spatial transcriptomic profiling reveals the pathophysiology of early-stage hidradenitis suppurativa.. 189. 2023
Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project.. 188. 2023
Clinical research: photo validation study using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) scores in patients with dermatomyositis.. 188. 2023
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.. 187. 2022
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes. 2022
Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.. 187. 2022
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study. 2021
Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa. 2021
Signalling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drives psoriasis-related inflammatory pathways.. 185. 2021
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.. 184. 2021
Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity.. 184. 2020
Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing.. 183. 2020
A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.. 182. 2019
Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel.. 182. 2019
Development of a new patient-reported outcome measure to evaluate treatments for acne and acne scarring: the ACNE-Q.. 181. 2019
Inter-rater reliability of phenotypes and exploratory genotype-phenotype analysis in inherited hidradenitis suppurativa.. 181. 2019
FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery.. 179. 2018
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis.. 175. 2016
Carbon dioxide laser ablation of basal cell carcinoma with visual guidance by reflectance confocal microscopy: a proof-of-principle pilot study.. 174. 2016
Multicentre study on inflammatory skin diseases from The International Confocal Working Group: specific confocal microscopy features and an algorithmic method of diagnosis.. 175. 2016
Cross-sectional analysis of the dermoscopic patterns and structures of melanocytic naevi on the back and legs of adolescents.. 173. 2015
Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial.. 173. 2015
A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis.. 173. 2015
Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC).. 172. 2015
Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences.. 172. 2014
Melanocytic naevi with globular and reticular dermoscopic patterns display distinct BRAF V600E expression profiles and histopathological patterns.. 171. 2014
Evaluating ex vivo fluorescence confocal microscopy images of basal cell carcinomas in Mohs excised tissue.. 171. 2014
Clinical and dermoscopic characteristics of new naevi in adults: results from a cohort study.. 169. 2013
Detection of skin cancer margins in Mohs excisions with high-speed strip mosaicing confocal microscopy: a feasibility study.. 169. 2013
Follicular cutaneous squamous cell carcinoma: an under-recognized neoplasm arising from hair appendage structures.. 169. 2013
In vivo reflectance confocal microscopy of shave biopsy wounds: feasibility of intraoperative mapping of cancer margins.. 163. 2010
Detection of basal cell carcinomas in Mohs excisions with fluorescence confocal mosaicing microscopy.. 160. 2009
Dermoscopic patterns and subclinical melanocytic nests in normal-appearing skin.. 160. 2009
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.. 159. 2008
Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis.. 159. 2008
Dermoscopic patterns of naevi in fifth grade children of the Framingham school system.. 158. 2008
Complex dermoscopic pattern: a potential risk marker for melanoma.. 158. 2008
Development and validation of the Dermatomyositis Skin Severity Index.. 158. 2007
The absence of apoeccrine glands in the human axilla has disease pathogenetic implications, including axillary hyperhidrosis.. 156. 2007
Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris.. 150. 2004
Ultrastructure of the hyperhidrotic eccrine sweat gland.. 145. 2001
Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225.. 144. 2001
The use of antibody to C5b-9 in the subclassification of lupus erythematosus.. 134. 1996
To see or not to see: a cross-sectional study suggesting lack of bias towards authors in the peer-review process. 2021
Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study.. 184. 2020
Treatment of severe cutaneous adverse reaction with tocilizumab.. 183. 2020
Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.. 183. 2020
Defining drug-free remission of skin disease in patients with plaque psoriasis.. 182. 2020
Interleukin 17C is elevated in lesional tissue of hidradenitis suppurativa.. 182. 2019
Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice.. 180. 2019
Can optical coherence tomography improve the management of basal cell carcinoma?. 180. 2019
Understanding racial disparities in mycosis fungoides through international collaborative studies.. 180. 2019
The optimal regimen of brentuximab vedotin for CD30⁺ cutaneous lymphoma: are we there yet?. 178. 2017
Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.. 177. 2017
Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'.. 176. 2017
Towards three-dimensional temporal monitoring of naevi: a comparison of methodologies for assessing longitudinal changes in skin surface area around naevi.. 175. 2016
How best to manage acral naevi.. 173. 2015
Video-mosaicing of reflectance confocal images for examination of extended areas of skin in vivo.. 171. 2014
Mass spectrometry-based proteomic analysis of cutaneous cryoglobulinaemia in formalin-fixed tissues.. 168. 2013
Urticarial vasculitis.. 135. 1996
Consensus on the clinical management of chronic radiation dermatitis and radiation fibrosis: a Delphi survey. 2022
The Keloid Area and Severity Index (KASI): An Objective Tool for the Evaluation of Keloids. 2022
Mycophenolate mofetil and methotrexate efficacy in dermatomyositis. 2022
Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma. 2022
The patient experience of pain in hidradenitis suppurativa. 2020
Near total body vitiligo secondary to immunotherapy for metastatic melanoma. 2020
Polyclonal hyperglobulinaemia and elevated acute-phase reactants in hidradenitis suppurativa. 2018
The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis. 2015
Parvovirus B19 and systemic sclerosis. 2005
Towards 'interpretable' artificial intelligence for dermatology.. 181. 2019
Beyond skin deep: taking bedside dermatology to the next level with noninvasive technologies.. 178. 2018
Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. 2013
Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research. 2007
Evaluation of diagnosis diversity in artificial intelligence datasets: a scoping review. 2023

VIVO Weill Cornell Medical College

The British journal of dermatology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)